AllianceBernstein’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44B Sell
6,948,656
-746,746
-10% -$174M 0.47% 32
2025
Q4
$1.59B Sell
7,695,402
-237,210
-3% -$46.9M 0.5% 29
2025
Q3
$1.47B Buy
7,932,612
+31,385
+0.4% +$5.38M 0.46% 37
2025
Q2
$1.21B Buy
7,901,227
+114,977
+1% +$17.7M 0.39% 49
2025
Q1
$1.29B Buy
7,786,250
+1,463,022
+23% +$229M 0.47% 41
2024
Q4
$914M Buy
6,323,228
+74,465
+1% +$11.5M 0.31% 62
2024
Q3
$1.01B Buy
6,248,763
+1,534,240
+33% +$244M 0.34% 55
2024
Q2
$689M Sell
4,714,523
-484,062
-9% -$72M 0.24% 77
2024
Q1
$822M Sell
5,198,585
-341,442
-6% -$54.3M 0.29% 65
2023
Q4
$868M Sell
5,540,027
-448,814
-7% -$68.8M 0.33% 60
2023
Q3
$933M Sell
5,988,841
-1,194,798
-17% -$197M 0.4% 53
2023
Q2
$1.19B Sell
7,183,639
-971,552
-12% -$157M 0.49% 39
2023
Q1
$1.26B Buy
8,155,191
+351,509
+5% +$56.8M 0.54% 34
2022
Q4
$1.38B Buy
7,803,682
+722,090
+10% +$125M 0.62% 23
2022
Q3
$1.16B Sell
7,081,592
-338,515
-5% -$57.3M 0.56% 27
2022
Q2
$1.32B Buy
7,420,107
+475,622
+7% +$84.7M 0.6% 25
2022
Q1
$1.23B Buy
6,944,485
+15,643
+0.2% +$2.66M 0.47% 32
2021
Q4
$1.19B Buy
6,928,842
+299,395
+5% +$49M 0.42% 41
2021
Q3
$1.07B Buy
6,629,447
+83,306
+1% +$14.2M 0.42% 39
2021
Q2
$1.08B Sell
6,546,141
-86,786
-1% -$14.4M 0.43% 36
2021
Q1
$1.09B Sell
6,632,927
-1,843,726
-22% -$298M 0.48% 34
2020
Q4
$1.33B Sell
8,476,653
-1,935,669
-19% -$286M 0.63% 26
2020
Q3
$1.55B Buy
10,412,322
+50,203
+0.5% +$7.43M 0.83% 16
2020
Q2
$1.46B Sell
10,362,119
-455,783
-4% -$66.4M 0.86% 15
2020
Q1
$1.42B Buy
10,817,902
+1,418,577
+15% +$201M 1.02% 12
2019
Q4
$1.37B Buy
9,399,325
+1,599,581
+21% +$217M 0.78% 19
2019
Q3
$1.01B Buy
7,799,744
+156,165
+2% +$20.6M 0.63% 25
2019
Q2
$1.06B Buy
7,643,579
+939,565
+14% +$130M 0.66% 24
2019
Q1
$937M Sell
6,704,014
-318,573
-5% -$42.7M 0.61% 29
2018
Q4
$906M Sell
7,022,587
-166,317
-2% -$23.2M 0.67% 23
2018
Q3
$993M Buy
7,188,904
+332,417
+5% +$44.2M 0.65% 23
2018
Q2
$832M Sell
6,856,487
-1,942,222
-22% -$242M 0.58% 26
2018
Q1
$1.13B Sell
8,798,709
-914,103
-9% -$124M 0.82% 15
2017
Q4
$1.36B Sell
9,712,812
-609,172
-6% -$84.9M 0.97% 10
2017
Q3
$1.34B Sell
10,321,984
-698,268
-6% -$92.6M 1.01% 10
2017
Q2
$1.46B Sell
11,020,252
-504,478
-4% -$64.4M 1.13% 9
2017
Q1
$1.44B Buy
11,524,730
+1,940,260
+20% +$232M 1.14% 7
2016
Q4
$1.1B Sell
9,584,470
-290,153
-3% -$33.5M 0.92% 12
2016
Q3
$1.17B Sell
9,874,623
-791,695
-7% -$96M 0.98% 12
2016
Q2
$1.29B Buy
10,666,318
+1,735,130
+19% +$197M 1.11% 12
2016
Q1
$966M Sell
8,931,188
-454,371
-5% -$47M 0.82% 16
2015
Q4
$964M Sell
9,385,559
-355,530
-4% -$35.8M 0.82% 18
2015
Q3
$909M Sell
9,741,089
-1,109,220
-10% -$107M 0.78% 16
2015
Q2
$1.06B Sell
10,850,309
-621,693
-5% -$62.3M 0.87% 12
2015
Q1
$1.15B Sell
11,472,002
-268,477
-2% -$27.3M 0.94% 9
2014
Q4
$1.23B Sell
11,740,479
-390,516
-3% -$41.2M 1.02% 9
2014
Q3
$1.29B Sell
12,130,995
-387,630
-3% -$40.2M 1.09% 7
2014
Q2
$1.31B Buy
12,518,625
+520,628
+4% +$52.6M 1.1% 8
2014
Q1
$1.18B Buy
11,997,997
+216,120
+2% +$20M 1.02% 7
2013
Q4
$1.08B Buy
11,781,877
+28,095
+0.2% +$2.59M 0.96% 6
2013
Q3
$1.02B Buy
11,753,782
+788,347
+7% +$70.7M 1.01% 6
2013
Q2
$941M Buy
+10,965,435
New +$931M 1% 6

Other funds holding JNJ

AllianceBernstein's JNJ Position: Q1 2026 in Review

AllianceBernstein reduced its Johnson & Johnson (JNJ) stake by 9.7% in Q1 2026, selling an estimated $174M and leaving 6,948,656 shares worth $1.44B. The position accounts for 0.47% of the portfolio, ranked #32.

AllianceBernstein first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.59B in Q4 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • AllianceBernstein held 6,948,656 shares of Johnson & Johnson worth $1.44B as of Q1 2026.
  • AllianceBernstein sold 746,746 Johnson & Johnson shares in Q1 2026, an estimated $174M.
  • Johnson & Johnson made up 0.47% of AllianceBernstein's portfolio in Q1 2026, its #32 holding.
  • AllianceBernstein first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • AllianceBernstein's Johnson & Johnson position peaked at $1.59B in Q4 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.